Delivery Order SPE2DB24D1201-SPE2DB25FJDRG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, a prescription opioid medication used for pain management. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 15, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,531.10 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 150 mg, a prescription opioid pain management medication. The award, made on May 20, 2025, with completion targeted for May 21, 2025, utilized firm fixed price contracting with no set-aside designation, indicating competitive award procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,810.39 for 60-count tablets of Nucynta ER 50 mg, an opioid pain management medication. Issued on September 4, 2025, with an ultimate completion date of September 5, 2025, this firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 200 mg, a prescription opioid pain management medication, with a contract ceiling value of $2,411.52. This is a firm fixed-price delivery order issued on August 6, 2025, with an ultimate completion date of August 7, 2025, with no set-aside designation. The place of performance is the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,013.96 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 150 mg, an extended-release opioid pain medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 25, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,914.75 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, a controlled-release pain management pharmaceutical. This contract type delivery order carries firm fixed pricing and was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $5,670.65 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, an extended-release opioid pain medication. This non-set-aside, firm fixed-price delivery order was awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Nucynta ER Tabs 100mg, a prescription opioid pain management medication. This firm fixed-price delivery order, valued at $9,992.08, represents a competitive award with no set-aside designation and is scheduled for completion by July 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,979.28 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 100 mg, a prescription opioid pain medication. This non-set-aside, competitively awarded delivery order reflects firm fixed pricing and was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 200 mg, a controlled-release pain management pharmaceutical, valued at $1,205.75. The contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, utilized firm fixed pricing with no set-aside designation, indicating competitive award procedures. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDRGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,761.86 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 200 mg, a prescription opioid pain medication. The contract, executed on July 28, 2025, with an ultimate completion date of July 29, 2025, employs firm fixed-price pricing with no set-aside designation, indicating competitive award status. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical prime vendor contract running through December 2026. The prime vendor arrangement enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and the Defense Health Agency. The company's extensive portfolio of federal contract awards demonstrates its established capability as a critical pharmaceutical distributor within the federal medical supply chain, serving defense and veteran healthcare systems with brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 7/28/25 |